ESC 365 - The TAB1-p38a complex is a therapeutic target in acute myocardial ischemia: the holy grail of circumstance selective inhibition of p38a.

Open Access

The TAB1-p38a complex is a therapeutic target in acute myocardial ischemia: the holy grail of circumstance selective inhibition of p38a.

Session: New strategies for cardioprotection to prevent heart failure

Topic: Ischaemia, Infarction, Cardioprotection

Speaker: Doctor G. De Nicola (London, GB)

Event: Frontiers in CardioVascular Biology 2018

Congress Presentation

Add to my library

About the speaker

Doctor Gian Felice De Nicola

King's College London, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

5 more presentations in this session

The gut hormone ghrelin in the modulation of cardiac metabolism and vascular resistance

Speaker: Professor F. Recchia (Pisa, IT)

Targeting inflammation for cardioprotection.

Speaker: Professor S. Lecour (Cape Town, ZA)

Multi-omics strategies for unbiased identification of novel therapeutic targets for cardioprotection.

Speaker: Professor P. Ferdinandy (Budapest, HU)

Proteomics of cardioprotection.

Speaker: Professor M. Mayr (London, GB)

Cardiac-specific overexpression of the transcription factor JunD promotes increased sensitivity to myocardial infarction

Speaker: Doctor A. Akhmedov (Zurich, CH)

Access the full session

New strategies for cardioprotection to prevent heart failure

Speakers: Doctor G. De Nicola, Professor F. Recchia, Professor S. Lecour, Professor P. Ferdinandy, Professor M. Mayr...

About the event

Frontiers in CardioVascular Biology 2018

20 April - 22 April 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources